Clinical and experimental immunology, 2020-05, Vol.200 (2), p.105-107
2020
Details
- Autor(en) / Beteiligte
- Titel
- Immune checkpoint inhibition: from molecules to clinical application
- Ist Teil von
- Clinical and experimental immunology, 2020-05, Vol.200 (2), p.105-107
- Ort / Verlag
- England: Oxford University Press
- Erscheinungsjahr
- 2020
- Link zum Volltext
- Quelle
- MEDLINE
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0009-9104eISSN: 1365-2249DOI: 10.1111/cei.13434Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7160649
- Format
- –
- Schlagworte
- Antineoplastic Agents - therapeutic use, CTLA-4 Antigen - antagonists & inhibitors, CTLA-4 Antigen - immunology, Humans, Immune checkpoint inhibitors, Neoplasm Proteins - antagonists & inhibitors, Neoplasm Proteins - immunology, Neoplasms - drug therapy, Neoplasms - immunology, Neoplasms - pathology, Programmed Cell Death 1 Receptor - antagonists & inhibitors, Programmed Cell Death 1 Receptor - immunology